United Kingdom
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • CH
    • DK
    • PL
  • News
  • UK
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
  • US
  • Africa
  • Artificial intelligence
  • Arts and design
  • Birmingham
  • Books
  • Boxing
  • Brexit
  • Bristol
  • Britain
  • Business
  • Celebrities
  • Computing
  • Cricket
  • Cycling
  • Economy
  • Edinburgh
  • England
  • Entertainment
  • Entrepreneurship
  • Environment
  • EU
  • F1
  • Fitness
  • Football
  • France
  • Gadgets
  • Genetics
  • Germany
  • Glasgow
  • Golf
  • Health
  • Healthcare
  • Internet
  • Jobs
  • Leeds
  • Liverpool
  • London
  • Manchester
  • Markets
  • Medication
  • Mental health
  • Mobile
  • Movies
  • Music
  • News
  • Northern Ireland
  • Nutrition
  • Personal finance
  • Physics
  • Racing
  • Royals
  • Rugby
  • Russia
  • Science
  • Scotland
  • Sheffield
  • Space
  • Spain
  • Sports
  • Technology
  • Tennis
  • TV
  • UK
  • Ukraine
  • United Kingdom
  • United States
  • Virtual reality
  • Wales
  • Wildlife
  • World
United Kingdom
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • CH
    • DK
    • PL
  • News
  • UK
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
  • US
  • Africa

Browsing Tag

FDA

148 posts
NNutrition
Jordan King
Read More

‘Miracle’ supplement recalled nationwide over death, diarrhea risks

  • 14 February 2026
A supplement described as from a “miracle tree” by a nutritional therapist has been recalled because of possible…
MMedication
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Read More

Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP

  • 13 February 2026
Disc Medicine Inc FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and…
MMedication
Hims & Hers compounder received FDA warning letter| STAT
Read More

Hims & Hers compounder received FDA warning letter| STAT

  • 10 February 2026
The Food and Drug Administration late last year issued a warning letter to MedisourceRx, a compounding pharmacy owned…
GGermany
Germany blocks Amazon price caps in e-commerce
Read More

Germany Bans Amazon from Price Controls

  • 6 February 2026
This Week’s Regulatory Updates Germany bans Amazon price caps: The Bundeskartellamt demands Amazon halt anti-competitive pricing and repay…
MMedication
Marty Makary addresses staff concerns over drug voucher program
Read More

Marty Makary addresses staff concerns over drug voucher program

  • 4 February 2026
WASHINGTON — At an employee town hall on Tuesday, Food and Drug Administration leaders tried to quell staff…
MMedication
Is It Too Late To Consider Revolution Medicines (RVMD) After Its Recent 50% Weekly Surge?
Read More

Will 2026 FDA Decisions on Afrezza and FUROSCIX Redefine MannKind’s (MNKD) Narrative

  • 22 January 2026
Earlier in January, MannKind Corporation outlined upcoming 2026 regulatory milestones, including FDA decisions on Afrezza label updates, a…
MMedication
FDA Goon Delivers Wild Take on Prescription Drug Safety
Read More

FDA Goon Delivers Wild Take on Prescription Drug Safety

  • 18 January 2026
FDA commissioner Marty Makary said it would be “magical” for consumers to see prescription drugs on pharmacy shelves…
MMedication
NRx submits 70,000-patient ketamine data to US FDA
Read More

NRx submits 70,000-patient ketamine data to US FDA

  • 14 January 2026
NRx Pharmaceuticals (Nasdaq: NRXP) will submit real-world evidence from over 70,000 patients treated with intravenous ketamine…
MMedication
Tylenol, Advil, Purina, Haribo face urgent FDA recall
Read More

Tylenol, Advil, Purina, Haribo face urgent FDA recall

  • 5 January 2026
While a car recall is one notice I never ignore, I can’t ever remember throwing out a single…
MMedication
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
Read More

FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

  • 29 December 2025
PLYMOUTH MEETING, Pa., Dec. 29, 2025 /PRNewswire/ — INOVIO (NASDAQ: INO), a biotechnology company focused on developing and…
United Kingdom
www.europesays.com